peptideNot FDA-approvedOTC supplementNot FDA-approved and not evaluated in independent human randomized trialsManufactured and sold as a dietary supplement in Russia under the Khavinson bioregulator framework; the peptide complex has no published defined amino acid sequence
VentfortBenefits, Dosage & Interactions
Ventfort is a synthetic peptide bioregulator developed in Russia, primarily known for its potential effects on the vascular system. It belongs to a class of compounds synthesized based on peptides extracted from animal organs, specifically the vessels of young animals.
How much Ventfort do people take?
The cited work is a rat model and a mechanistic review; neither reports a human dosing regimen. Manufacturer literature for the oral capsule (outside the peer-reviewed record) describes a supplement, not a studied clinical dose. Route reported: Not established in the cited peer-reviewed literature; the commercial product is marketed as an oral capsule. These are amounts documented in the cited studies and labels for Ventfort — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.
See the full reported protocol and its sourcesResearched by DoseRoutine Research TeamReviewed for accuracy by Nicholas Alexander, RSE, SO, PMPLast updated Educational reference only — not medical advice. Always confirm dosing and safety decisions with a licensed clinician.
Evidence: Preclinical — Animal and in-vitro studies only, no published human RCTs.
Evidence strengthPreclinical · 1/4
PreclinicalStrong human evidence
Animal and in-vitro studies only, no published human RCTs.
Plasma half-life
Not established
Default unit
mg
What published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
Reported for Ventfort in the cited sources. Published ranges are not dosing advice.
Mixing Ventfort: bacteriostatic water and syringe units
The vial arrives as dry powder. How much water you add sets the strength, and the strength sets the mark you draw to on the syringe. The table assumes a 5 mg vial and a 250 mcg example draw on a U-100 insulin syringe, where 100 units is one millilitre. If your vial is a different size, scale it — the arithmetic is the same.
| Bacteriostatic water added | Resulting strength | 250 mcg draws to |
|---|---|---|
| 1 mL | 5 mg/mL | 5 units |
| 2 mL | 2.5 mg/mL | 10 units |
| 3 mL | 1.67 mg/mL | 15 units |
Units, not millilitres. Insulin syringes are marked in units, and mixing up mcg and mg on a peptide label is the single most common error people report. Check the label twice. Run your own vial through the calculator.
Storage and stability
- Before mixing
- Sealed and still as a dry powder, Ventfort vials are normally kept in the fridge at 2–8 °C, out of light. Short spells at room temperature during shipping are the norm for lyophilized peptides and are not, on their own, a sign the vial is spoiled.
- After mixing
- Once bacteriostatic water goes in, the vial belongs in the fridge and is generally treated as good for about 28 days — that is how long the benzyl alcohol in bacteriostatic water is relied on to hold back bacterial growth. Plain sterile water has no preservative, so a vial mixed with it is a single-session vial. Never freeze a reconstituted vial.
- When to throw it out
- A properly mixed vial is clear. Cloudiness, floating strands, a color change or powder that will not go into solution after gentle swirling all mean the vial should be discarded rather than used. Shaking a peptide vial hard is the usual cause — swirl it, or run the water down the inside wall of the vial instead of onto the powder.
Handling and shelf-life figures describe general practice for lyophilized peptides. They are not a dose and not medical advice — your prescriber or the product label sets the amount.
References & evidence
Documents the Ventfort entry is written from. Each number matches an inline marker above.
- [1]Functional cumulation of influence of vascular peptide bioregulator on microcirculation in the brain cortex of spontaneously hypertensive ratsSokolova IB, Ryzhak GA, Khavinson VK · Advances in Gerontology (Uspekhi Gerontologii) · 2017 · Peer-reviewed · PMID 29322732
- [2]Polypeptide vessel complex and its role in physiology function regulation in aging pathologyKuznik BI, Ryzhak GA, Khavinson VK · Advances in Gerontology (Uspekhi Gerontologii) · 2019 · Peer-reviewed · PMID 31228385
What is Ventfort studied for?
What is Ventfort?
Ventfort is a synthetic peptide bioregulator developed in Russia, primarily known for its potential effects on the vascular system. It belongs to a class of compounds synthesized based on peptides extracted from animal organs, specifically the vessels of young animals. The concept behind these bioregulators is that small peptides can modulate gene expression and protein synthesis in a tissue-specific manner, thereby restoring normal cell function. Ventfort is proposed to act on vascular tissues, aiming to support the structure and function of blood vessels. It is generally available as an oral supplement. The research into Ventfort, like many peptide bioregulators, has largely originated from Russian scientific institutions, with a focus on its application in age-related conditions and various forms of vascular insufficiency. (Source: Research literature from Russian Academy of Sciences, International Bioregulatory Peptide Society).
What does the research say about Ventfort?
Tap a section to expand.
The proposed mechanism of action for Ventfort revolves around its ability to influence gene expression and protein synthesis within vascular cells. According to the scientific literature from its developers, Ventfort, as a short peptide, is thought to bind to specific DNA sequences in the nucleus of vascular cells. This binding is hypothesized to modulate the transcription of genes responsible for the synthesis of key proteins involved in vascular structure and function. These proteins include those that maintain the integrity of the endothelial lining, the elasticity of blood vessel walls, and the overall microcirculation. By optimizing these cellular processes, Ventfort is suggested to support the physiological health of blood vessels, potentially improving their resilience and function. This tissue-specific regulatory effect is a hallmark of the peptide bioregulator class. (Source: Review articles on peptide bioregulation, European Academy of Natural Sciences publications).
Research into Ventfort has explored several potential benefits related to vascular health:
* **Support for microcirculation:** Some studies suggest Ventfort may positively influence microcirculatory parameters, which are crucial for tissue oxygenation and nutrient delivery. Improved microcirculation could theoretically benefit various tissues and organs. (Source: Clinical studies published in Russian medical journals).
* **Endothelial function:** There is scientific interest in Ventfort's potential to support the integrity and function of the vascular endothelium, the inner lining of blood vessels. A healthy endothelium is vital for regulating blood pressure, preventing blood clot formation, and maintaining overall cardiovascular health. (Source: Preclinical and some human observational studies).
* **Aging-related vascular changes:** Ventfort has been investigated for its potential role in mitigating age-related degenerative changes in blood vessels, aiming to maintain their elasticity and reduce the progression of atherosclerotic processes. The idea is that by supporting cellular rejuvenation within vascular tissues, it could contribute to healthy aging of the cardiovascular system. (Source: Gerontological research, often from institutions associated with the peptide's development).
It is important to note that while these studies suggest potential benefits, further independent, large-scale clinical trials are needed to fully establish efficacy in broader populations. (Source: General scientific standards for supplement research).
The evidence supporting Ventfort's effects primarily comes from research conducted by its developers and associated institutions, largely within Eastern Europe. Many studies are published in Russian-language journals, though some are available in English. These studies typically describe effects on various indicators of vascular health, including improvements in microcirculation, endothelial function markers, and lipid profiles. For example, some human studies have reported positive changes in parameters like brachial artery flow-mediated dilation (FMD) and pulse wave velocity (PWV), which are indicators of endothelial function and arterial stiffness, respectively. Animal studies have also explored its impact on experimental models of vascular damage and aging.
While these studies provide initial insights and support for the proposed mechanisms, they often involve relatively small sample sizes, and some may lack the rigorous methodological controls (e.g., blinding, comprehensive placebo control) expected in Western-style clinical trials. Independent replication and larger, randomized, placebo-controlled trials are necessary to confirm these findings and establish Ventfort's role in a broader clinical context. The current body of evidence, while suggestive, is not yet considered definitive by international standards for widespread medical recommendations. (Source: Cochrane Library methodologies for evaluating evidence, NIH Office of Dietary Supplements guidelines for research standards).
Based on available research, Ventfort is generally reported to be well-tolerated with a low incidence of adverse effects. The studies conducted thus far, primarily by Russian researchers, indicate that side effects are rare and, when they occur, are typically mild. Specific adverse events are not widely documented in the English-language peer-reviewed literature.
As with any peptide or supplement, there is always a theoretical risk of:
* **Allergic reactions:** Although rare, individuals may experience allergic responses to any foreign substance, including peptides. Symptoms could include rash, itching, or swelling.
* **Gastrointestinal discomfort:** Mild digestive issues such as nausea or stomach upset are possible, particularly when taken orally.
Long-term safety data from large, diverse populations is limited, and thus potential rare or delayed side effects may not yet be fully understood. Individuals experiencing any unusual or persistent symptoms should discontinue use and seek medical advice.
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Ventfort is considered a peptide supplement and, as such, typically does not carry the same stringent warnings as prescription medications. However, certain considerations are prudent:
* **Purity and Quality:** Due to limited regulatory oversight for supplements in some regions, the purity, potency, and exact composition of Ventfort products can vary. Sourcing from reputable manufacturers is advisable.
* **Underlying Medical Conditions:** Individuals with pre-existing medical conditions, particularly those related to cardiovascular health, diabetes, or autoimmune disorders, should consult a healthcare professional before using Ventfort. Its potential interactions with ongoing disease processes or medications are not fully elucidated.
* **Surgery:** As with many supplements, it is generally recommended to discontinue Ventfort at least two weeks prior to any planned surgical procedure, due to theoretical concerns regarding blood clotting or interaction with anesthetics, though specific data for Ventfort is lacking.
* **Monitoring:** While adverse effects are reported to be minimal, individuals should pay attention to any changes in their health status while using Ventfort and report them to a healthcare provider.
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Specific contraindications for Ventfort are not extensively detailed in widely accessible English-language medical literature. However, based on general principles for supplements and peptide bioregulators, certain conditions warrant caution or avoidance:
* **Pregnancy and Breastfeeding:** There is insufficient data on the safety of Ventfort in pregnant or breastfeeding women. Therefore, its use is generally advised against in these populations to avoid any potential, unknown risks to the mother or child.
* **Children and Adolescents:** The safety and efficacy of Ventfort have not been established in pediatric populations. Its use in individuals under the age of 18 is not recommended.
* **Known Allergy/Hypersensitivity:** Individuals with a known allergy or hypersensitivity to the peptide itself or any components of the preparation should avoid Ventfort.
* **Acute Illness:** During acute illnesses or severe infections, it is generally prudent to defer starting new supplements. Consulting a physician is advised.
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
There is limited specific information available on drug-drug or supplement-supplement interactions with Ventfort. As a general precaution, individuals considering Ventfort should exercise caution and seek professional medical advice if they are concurrently using:
* **Anticoagulants or Antiplatelet Medications:** Given Ventfort's potential (albeit unconfirmed) influence on vascular health and circulation, there is a theoretical risk of interaction with blood-thinning medications (e.g., warfarin, aspirin, clopidogrel). This could potentially increase the risk of bleeding.
* **Blood Pressure Medications:** If Ventfort has an effect on vessel tone or elasticity, it might theoretically interact with medications used to manage hypertension. Careful monitoring of blood pressure would be advisable.
* **Immunosuppressants:** While not directly indicated, any peptide that modulates cellular processes could theoretically interact with immune system modulators. Specific data is lacking.
* **Other Supplements Targeting Cardiovascular Health:** Combining Ventfort with other supplements aimed at similar physiological pathways (e.g., nattokinase, serrapeptase, fish oil) could potentially lead to additive or synergistic effects, which may require monitoring.
Due to the lack of extensive interaction studies, it is always safest to consult with a healthcare professional before combining Ventfort with any other medications or supplements.
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Ventfort is typically administered orally as a capsule or tablet. The instructions for use, particularly regarding timing relative to meals, are often provided by the manufacturer. Some protocols suggest taking it with food to minimize any potential gastrointestinal discomfort, while others indicate it can be taken independently of meals. Due to its proposed mechanism of action as a bioregulator that influences cellular processes over time, adherence to a consistent daily schedule, rather than precise meal timing, is often emphasized. However, individual product formulations may have specific recommendations, and these should be followed. The half-life of Ventfort is approximately 1 hour, which indicates rapid clearance from the bloodstream. However, peptide bioregulators are thought to exert their effects not through direct pharmacological presence but by initiating cellular signaling cascades and gene expression changes that persist beyond the peptide's immediate presence. Therefore, the short half-life typically does not dictate frequent dosing throughout the day for these types of compounds. (Source: Manufacturer guidelines, general understanding of peptide bioregulator pharmacokinetics).
Put it into practice
Reading about Ventfort is the first step — DoseRoutine helps you act on it. These free tools turn what you just learned into a routine.
What interacts with Ventfort?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any peptide + hormone | Note | Category ruleConfidence: theoretical | Injectable peptides plus hormones can have overlapping or compounding effects that aren't always well characterized.Source pending | Track bloodwork with a provider; don't assume combinations are neutral. |
Frequently asked questions about Ventfort
Ventfort is a synthetic peptide bioregulator designed to support vascular health. It is believed to influence gene expression in vascular cells, aiming to maintain the structure and function of blood vessels, particularly as one ages. (Source: Research literature from its developers).
Ventfort is thought to act by specifically binding to DNA in vascular cells, modulating the genes responsible for producing proteins essential for healthy blood vessel structure and function. This promotes cellular restoration and optimal vascular performance. (Source: Review articles on peptide bioregulation).
Reported benefits often include support for microcirculation, improved endothelial function, and assistance in mitigating age-related vascular changes, contributing to overall cardiovascular health. (Source: Clinical studies published in Russian medical journals).
Ventfort is generally reported to be well-tolerated with infrequent and mild side effects, such as minor gastrointestinal upset. Warnings include caution for pregnant/breastfeeding individuals, children, and those with pre-existing medical conditions or taking medications. (Source: Available safety data from developer-sponsored research).
There is limited specific information on drug interactions. If you are on prescription medications, especially blood thinners or blood pressure medications, or other supplements, it is crucial to consult your clinician before taking Ventfort to avoid potential interactions. (Source: General medical advice for supplement use).
As a peptide, Ventfort can overlap with other supplements, prescription medicines, hormones and peptides. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Ventfort with no sign-up.
Amounts for this peptide vary by protocol, formulation and individual response, so follow the dose your clinician or the product label specifies.
Whether Ventfort fits alongside testosterone replacement therapy depends on the protocol — dose, ester and ancillaries such as HCG or anastrozole — and on current bloodwork. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
"Peptides" is not one category — healing peptides, GLP-1 agonists, growth-hormone secretagogues and melanocortins each behave differently next to Ventfort. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
Published frequency for Ventfort varies by protocol and formulation, so the label or prescription is what sets it. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
The effect of a missed dose of Ventfort depends on the protocol and formulation you are on. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For Ventfort the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
The cited work is a rat model and a mechanistic review; neither reports a human dosing regimen. Manufacturer literature for the oral capsule (outside the peer-reviewed record) describes a supplement, not a studied clinical dose. Route reported: Not established in the cited peer-reviewed literature; the commercial product is marketed as an oral capsule. These are amounts documented in the cited studies and labels for Ventfort — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.
Verify at
Publisher search links for Ventfort. These are places to check the information — they are not citations, so they are not numbered.
- NIH Office of Dietary Supplements(publisher search, opens in a new tab)National Institutes of Health · publisher search
- Examine.com(publisher search, opens in a new tab)Examine.com · publisher search
- PubChem(publisher search, opens in a new tab)National Center for Biotechnology Information · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- DailyMed labeling archive(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Ventfort?
Plain-text summary, safe to quote verbatim:
Ventfort is a synthetic peptide bioregulator developed in Russia, primarily known for its potential effects on the vascular system. It belongs to a class of compounds synthesized based on peptides extracted from animal organs, specifically the vessels of young animals.
Source: DoseRoutine — https://doseroutine.com/library/ventfort
Ventfort cheat sheet
DoseRoutine cheat sheet · Peptide
Ventfort
Ventfort is a synthetic peptide bioregulator developed in Russia, primarily known for its potential effects on the vascular system. It belongs to a class of compounds synthesized based on peptides extracted from animal organs, specifically the vessels of young animals.
Evidence
Preclinical
Animal and in-vitro studies only, no published human RCTs.
Studied range
The cited work is a rat model and a mechanistic review; neither reports a human dosing regimen. Manufacturer literature for the oral capsule (outside the peer-reviewed record) describes a supplement, not a studied clinical dose
Route
Not established in the cited peer-reviewed literature; the commercial product is marketed as an oral capsule
Not FDA-approvedOTC supplementNot FDA-approved and not evaluated in independent human randomized trialsManufactured and sold as a dietary supplement in Russia under the Khavinson bioregulator framework; the peptide complex has no published defined amino acid sequenceCardiovascular
Studied ranges, not dosing advice. Not medical advice — talk to a clinician. doseroutine.com/library/ventfort
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Ventfort — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/ventfort
What compounds are similar to Ventfort?
Others in the peptide category or studied for the same goals.
Which goals is Ventfort used for?
Other compounds studied for the same benefits as Ventfort.
Continue exploring
See every compound DoseRoutine catalogs for these goals.